The role of inflammation in diabetic eye disease
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2019/06/07
-
Journal
-
Indian UGC (journal)
-
Refrences191
-
Citations81
-
Marina Mesquida ORCID (unauthenticated)
-
Faye Drawnel
-
Sascha Fauser
Cite
Mesquida, Marina, et al. “The Role of Inflammation in Diabetic Eye Disease”. Seminars in Immunopathology, vol. 41, no. 4, 2019, pp. 427-45, https://doi.org/10.1007/s00281-019-00750-7.
Mesquida, M., Drawnel, F., & Fauser, S. (2019). The role of inflammation in diabetic eye disease. Seminars in Immunopathology, 41(4), 427-445. https://doi.org/10.1007/s00281-019-00750-7
Mesquida, Marina, Faye Drawnel, and Sascha Fauser. “The Role of Inflammation in Diabetic Eye Disease”. Seminars in Immunopathology 41, no. 4 (2019): 427-45. https://doi.org/10.1007/s00281-019-00750-7.
Mesquida M, Drawnel F, Fauser S. The role of inflammation in diabetic eye disease. Seminars in Immunopathology. 2019;41(4):427-45.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Immunologic diseases
Allergy
Medicine
Medicine (General)
Medicine
Pathology
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema | Diabetes |
| 53 | 2015 |
| Ocular Application of the Kinin B1 Receptor Antagonist LF22-0542 Inhibits Retinal Inflammation and Oxidative Stress in Streptozotocin-Diabetic Rats | PLOS ONE |
| 43 | 2012 |
Infliximab for Diabetic Macular Edema Refractory to Laser Photocoagulation | Diabetes Care |
| 63 | 2010 |
| Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor | Journal of Biological Chemistry |
| 713 | 1996 |
| The potent small molecule integrin antagonist THR-687 is a promising next-generation therapy for retinal vascular disorders | Experimental Eye Research |
| 22 | 2019 |
Refrences Analysis
The category
Medicine: Medicine (General) 97
is the most frequently represented among the references in this article. It primarily includes studies from Ophthalmology and Diabetes. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
A New Modulator of Neuroinflammation in Diabetic Retinopathy: USP25 | Inflammation |
| 2024 | |
| Circulating immune cell phenotyping is potentially relevant for diabetic retinopathy risk assessment | Diabetes Research and Clinical Practice |
| 2024 | |
| The effectiveness and safety of Chinese patent medicines plus calcium dobesilate for the treatment of diabetic retinopathy: A network meta-analysis | Heliyon | 2024 | ||
| Evaluating the protective effects of dexamethasone and electrospun mesh combination on primary human mixed retinal cells under hyperglycemic stress | International Journal of Pharmaceutics |
| 2024 | |
| A single cell atlas of circulating immune cells involved in diabetic retinopathy | iScience | 2024 |
Citations Analysis
The category
Medicine: Medicine (General) 29
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Inflammation and type 2 diabetes: from basic science to treatment and was published in 2019. The most recent citation comes from a 2024 study titled Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy. This article reached its peak citation in 2021, with 24 citations. It has been cited in 66 different journals, 34% of which are open access. Among related journals, the Frontiers in Pharmacology cited this research the most, with 6 citations. The chart below illustrates the annual citation trends for this article.